Cargando…
Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays
The NS2B-NS3 protease (NS2B-NS3pro) is regarded as an interesting molecular target for drug design, discovery, and development because of its essential role in the Zika virus (ZIKV) cycle. Although no NS2B-NS3pro inhibitors have reached clinical trials, the employment of drug-like scaffolds can faci...
Autores principales: | Santos, Lucianna H., Rocha, Rafael E. O., Dias, Diego L., Ribeiro, Beatriz M. R. M., Serafim, Mateus Sá M., Abrahão, Jônatas S., Ferreira, Rafaela S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537087/ https://www.ncbi.nlm.nih.gov/pubmed/37765127 http://dx.doi.org/10.3390/ph16091319 |
Ejemplares similares
-
Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease
por: Kumar, Ankur, et al.
Publicado: (2018) -
Ligand Accessibility Insights to the Dengue Virus NS3‐NS2B Protease Assessed by Long‐Timescale Molecular Dynamics Simulations
por: Kronenberger, Thales, et al.
Publicado: (2021) -
Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease
por: Choudhry, Hani, et al.
Publicado: (2019) -
Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication()
por: Lin, Wen-Wei, et al.
Publicado: (2023) -
Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in “Super-Open” Conformation
por: Meewan, Ittipat, et al.
Publicado: (2023)